The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group — G.F. Samelis (2003) | RDL Network
The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group
D. Pectasides, Gerasimos Aravantinos, Haralabos P. Kalofonos, Christos Kiamouris, D. Bafaloukos, Nikolaos I. Xiros, C. Nicolaides, A. Visvikis, Meletios A Dimopoulos
Meletios A Dimopoulos, George Fountzilas, E. Papageorgiou, Christos Kiamouris, George Mantzios, Athanassios Anagnostopoulos, C. Nicolaides, Theofanis Economopoulos
George Fountzilas, Meletios A Dimopoulos, C. Papadimitriou, Anna Kalogera‐Fountzila, Gerasimos Aravantinos, Dimitrios Bafaloukos, A. Athanassiades, C. Nicolaides, Antonios Keramopoulos, Nicholas Pavlidis, P. Kosmidis, Dimosthenis Skarlos
Meletios A Dimopoulos, C. Bakoyannis, Vassilis Georgoulias, Christos Papadimitriou, Lia A. Moulopoulos, C. Deliveliotis, A. Karayannis, Ioannis Varkarakis, Gerasimos Aravantinos, Anastasios Zervas, D Pantazopoulos, George Fountzilas, Aristotelis Bamias, Zacharias Kyriakakis, Αchilles Anagnostopoulos, Αθανάσιος Γιαννόπουλος, P. Kosmidis
Discussion(0)
No comments yet. Be the first to comment.